242 related articles for article (PubMed ID: 24694071)
1. New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile.
Gordeev MF; Yuan ZY
J Med Chem; 2014 Jun; 57(11):4487-97. PubMed ID: 24694071
[TBL] [Abstract][Full Text] [Related]
2. Linezolid--a review of the first oxazolidinone.
Norrby R
Expert Opin Pharmacother; 2001 Feb; 2(2):293-302. PubMed ID: 11336587
[TBL] [Abstract][Full Text] [Related]
3. Tedizolid: a new oxazolidinone antimicrobial.
Kisgen JJ; Mansour H; Unger NR; Childs LM
Am J Health Syst Pharm; 2014 Apr; 71(8):621-33. PubMed ID: 24688035
[TBL] [Abstract][Full Text] [Related]
4. Have the oxazolidinones lived up to their billing? Future perspectives for this antibacterial class.
Nilius AM
Curr Opin Investig Drugs; 2003 Feb; 4(2):149-55. PubMed ID: 12669374
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro activity of novel 1,2,4-triazolo[4,3-a]pyrimidine oxazolidinone antibacterial agents.
Khera MK; Cliffe IA; Mathur T; Prakash O
Bioorg Med Chem Lett; 2011 May; 21(10):2887-9. PubMed ID: 21507643
[TBL] [Abstract][Full Text] [Related]
6. Oxazolidinone antimicrobials: a patent review (2012-2015).
Phillips OA; Sharaf LH
Expert Opin Ther Pat; 2016 May; 26(5):591-605. PubMed ID: 26998627
[TBL] [Abstract][Full Text] [Related]
7. Oxazolidinone structure-activity relationships leading to linezolid.
Barbachyn MR; Ford CW
Angew Chem Int Ed Engl; 2003 May; 42(18):2010-23. PubMed ID: 12746812
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of 5-substituted oxazolidinones.
Phillips OA; Udo EE; Ali AA; Al-Hassawi N
Bioorg Med Chem; 2003 Jan; 11(1):35-41. PubMed ID: 12467705
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of novel 5-(4-methyl-1H-1,2,3-triazole) methyl oxazolidinones.
Phillips OA; Udo EE; Abdel-Hamid ME; Varghese R
Eur J Med Chem; 2009 Aug; 44(8):3217-27. PubMed ID: 19376613
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives.
Phillips OA; D'Silva R; Bahta TO; Sharaf LH; Udo EE; Benov L; Eric Walters D
Eur J Med Chem; 2015 Dec; 106():120-31. PubMed ID: 26536532
[TBL] [Abstract][Full Text] [Related]
11. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the monoamine oxidases inhibitory activity of a small series of 5-(azole)methyl oxazolidinones.
Phillips OA; Sharaf LH; D'Silva R; Udo EE; Benov L
Eur J Pharm Sci; 2015 Apr; 71():56-61. PubMed ID: 25701103
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial oxazolidinones: emerging structure-toxicity relationships.
Renslo AR
Expert Rev Anti Infect Ther; 2010 May; 8(5):565-74. PubMed ID: 20455685
[TBL] [Abstract][Full Text] [Related]
14. Oxazolidinone antibiotics.
Diekema DJ; Jones RN
Lancet; 2001 Dec; 358(9297):1975-82. PubMed ID: 11747939
[TBL] [Abstract][Full Text] [Related]
15. Linezolid.
Narang M; Gomber S
Indian Pediatr; 2004 Nov; 41(11):1129-32. PubMed ID: 15591662
[TBL] [Abstract][Full Text] [Related]
16. The synthesis and antibacterial activity of 1,3,4-thiadiazole phenyl oxazolidinone analogues.
Thomasco LM; Gadwood RC; Weaver EA; Ochoada JM; Ford CW; Zurenko GE; Hamel JC; Stapert D; Moerman JK; Schaadt RD; Yagi BH
Bioorg Med Chem Lett; 2003 Dec; 13(23):4193-6. PubMed ID: 14622999
[TBL] [Abstract][Full Text] [Related]
17. New oxazolidinones.
Vara Prasad JV
Curr Opin Microbiol; 2007 Oct; 10(5):454-60. PubMed ID: 17928263
[TBL] [Abstract][Full Text] [Related]
18. Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.
Douros A; Grabowski K; Stahlmann R
Expert Opin Drug Metab Toxicol; 2015; 11(12):1849-59. PubMed ID: 26457865
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship in the oxazolidinone-quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of action.
Hubschwerlen C; Specklin JL; Baeschlin DK; Borer Y; Haefeli S; Sigwalt C; Schroeder S; Locher HH
Bioorg Med Chem Lett; 2003 Dec; 13(23):4229-33. PubMed ID: 14623007
[TBL] [Abstract][Full Text] [Related]
20. The synthesis and biological evaluation of a novel series of antimicrobials of the oxazolidinone class.
Sciotti RJ; Pliushchev M; Wiedeman PE; Balli D; Flamm R; Nilius AM; Marsh K; Stolarik D; Jolly R; Ulrich R; Djuric SW
Bioorg Med Chem Lett; 2002 Aug; 12(16):2121-3. PubMed ID: 12127518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
